Glenmark Pharmaceuticals Ltd. Fundamental & Technical Research, Share Price Today

NSE : GLENMARK
NIFTY : NIFTY Midcap 100
NIFTY SECTOR : Nifty Pharma

About Company

Glenmark Pharmaceuticals Limited is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Specialty Business: Drug Discovery: Glenmark’s ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain]. Specialty Business: Formulations Business: Glenmark’s formulations business is currently organized many regions - India, Latin America, Central Eastern Europe and Semi Regulated Markets of Africa/Asia/CIS. The formulations business focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology.

Market Cap. ₹ 55,704 Cr.

52 Week - High/Low ₹ 2,285/1,276

P/E Ratio 37.46

P/B Ratio 2.42

Enterprise Value ₹ 55,856 Cr.

ROE % 25.3

RSI Value 42.73

EMA 50 1919.45

EMA 200 1624.83

Market Cap. ₹ 55,704 Cr.

52 Week - High/Low ₹ 2,285/1,276

P/E Ratio 73.93

P/B Ratio 7.10

Enterprise Value ₹ 55,261 Cr.

ROE % -21.18

RSI Value 42.73

EMA 50 1919.45

EMA 200 1624.83

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us